Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $728,838 | $669,950 | $814,490 | $1,186,210 |
| - Cash | $43,277 | $35,622 | $33,358 | $124,968 |
| + Debt | $2,893 | $3,003 | $2,916 | $2,602 |
| Enterprise Value | $688,454 | $637,331 | $784,048 | $1,063,844 |
| Revenue | $39,795 | $33,908 | $30,761 | $29,208 |
| % Growth | 17.4% | 10.2% | 5.3% | – |
| Gross Profit | $35,315 | $30,143 | $27,877 | $26,226 |
| % Margin | 88.7% | 88.9% | 90.6% | 89.8% |
| EBITDA | -$18,787 | -$29,358 | -$35,102 | -$58,481 |
| % Margin | -47.2% | -86.6% | -114.1% | -200.2% |
| Net Income | -$19,726 | -$30,322 | -$35,996 | -$65,714 |
| % Margin | -49.6% | -89.4% | -117% | -225% |
| EPS Diluted | -0.19 | -0.29 | -0.35 | -0.7 |
| % Growth | 34.5% | 17.1% | 50% | – |
| Operating Cash Flow | -$5,805 | -$24,806 | -$58,997 | -$30,008 |
| Capital Expenditures | $0 | $3,497 | -$3,817 | -$1,419 |
| Free Cash Flow | -$5,805 | -$21,309 | -$62,814 | -$31,427 |